Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.

Simon Peter Gampenrieder; G Rinnerthaler; H Hackl; M Steiner; C Monzo Fuentes; Clemens Hufnagl; C Hauser-Kronberger; A Egle; Richard Greil

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.

Simon Peter Gampenrieder, G Rinnerthaler, H Hackl, M Steiner, C Monzo Fuentes, Clemens Hufnagl, C Hauser-Kronberger, A Egle, Richard Greil

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center
Institute of Pathology

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - 2017
Event	ESMO 2017 Congress - Madrid, Spain Duration: 8 Sept 2017 → 12 Sept 2017

Conference with scientific content

Conference with scientific content	ESMO 2017 Congress
Country/Territory	Spain
City	Madrid
Period	8/09/17 → 12/09/17

1 Abstract

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.
Gampenrieder, S. P., Rinnerthaler, G., Hackl, H., Steiner, M., Monzo Fuentes, C., Hufnagl, C., Hauser-Kronberger, C., Egle, A. & Greil, R., 2017.
Research output: Contribution to conference › Abstract

Cite this

@conference{764f59079bd74c568215214ef6f40376,

title = "Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.",

author = "Gampenrieder, {Simon Peter} and G Rinnerthaler and H Hackl and M Steiner and {Monzo Fuentes}, C and Clemens Hufnagl and C Hauser-Kronberger and A Egle and Richard Greil",

year = "2017",

language = "English",

note = "ESMO 2017 Congress ; Conference date: 08-09-2017 Through 12-09-2017",

}

TY - CONF

T1 - Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial.

AU - Gampenrieder, Simon Peter

AU - Rinnerthaler, G

AU - Hackl, H

AU - Steiner, M

AU - Monzo Fuentes, C

AU - Hufnagl, Clemens

AU - Hauser-Kronberger, C

AU - Egle, A

AU - Greil, Richard

PY - 2017

Y1 - 2017

M3 - Poster

T2 - ESMO 2017 Congress

Y2 - 8 September 2017 through 12 September 2017

ER -